Irinotecan Hikma 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung New
Recall
|
Medicines
|
10/10/2025
The marketing authorisation holder informed its customers on October 10, 2025, that the mentioned batch is being recalled as precautionary measure due to crystallization on the outer neck of the bottle.
| Name of the medicinal product | Irinotecan Hikma 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-29063 |
| CIP code | 5503042 |
| Marketing authorisation holder | Hikma Farmaceutica (Portugal) S.A. |
| Distributor | Hikma Pharma GmbH |
| Batch number(s) | AC0467 |
| Expiry date | 08/31/2027 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5364 |
Further inquiry note
Page last modified:
10/10/2025